0001136261-14-000082 Sample Contracts

AutoNDA by SimpleDocs
Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. DEVELOPMENT AND LICENSE AGREEMENT DATED MARCH 18, 1996 BETWEEN NPS PHARMACEUTICALS, INC. AND AMGEN INC....
Confidential Treatment Requested • February 18th, 2014 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California

THIS DEVELOPMENT AND LICENSE AGREEMENT (this "Agreement") effective as of the 27th day of December, 1995 is by and between NPS Pharmaceuticals, Inc., a Delaware corporation ("NPS") having a place of business located at 420 Chipeta Way, Salt Lake City, Utah 84108, and Amgen Inc., a Delaware corporation ("Amgen") having a place of business located at Amgen Center, 1840 DeHavilland Drive, Thousand Oaks, California 91320-1789.

Contract Manufacture and Supply Agreement (Teduglutide Unlabelled Bulk Vials) between Nycomed Danmark ApS Langebjerg 1 4000 Roskilde Danmark and Patheon UK Limited Kingfisher Drive Covingham, Swindon, SN3 5BZ England
Confidential Treatment Requested • February 18th, 2014 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)

This Contract Manufacture and Supply Agreement relating to the Teduglutide unlabelled bulk lyo vials is being entered into by and between Nycomed Danmark ApS, Langebjerg 1, 4000 Roskilde, Denmark, ("Nycomed"), and Patheon UK Limited, a company incorporated in England & Wales (registered number 3764421) with registered office at Kingfisher Drive, Covingham, Swindon, Wiltshire, SN3 58Z, England ("Patheon"). Each or both of Nycomed and Patheon are hereinafter referred to as "Party" or "Parties", as intended in the given context.

Time is Money Join Law Insider Premium to draft better contracts faster.